Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Drug Research
Drug Delivery
Return to: PBR Home | Drug Research | Drug Delivery

Drug Delivery

European Commission approves Novartis' Signifor to treat patients with acromegaly By PBR Staff Writer
The European Commission has granted approval for Swiss drugmaker Novartis' Signifor (pasireotide) as a new long acting release formulation for once monthly intramuscular injection to treat adult patients with acromegaly.
Drug Research > Drug Delivery > News
Novo Nordisk's Victoza gets CHMP positive opinion to treat adults with type 2 diabetes By PBR Staff Writer
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the use of Novo Nordisk's Victoza (liraglutide), to treat adults with type 2 diabetes and moderate renal impairment.
Drug Research > Drug Delivery > News Baxter recalls one lot of highly concentrated potassium chloride injection in US Baxter International is voluntarily recalling one lot of Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL to the user level due to a complaint of mislabeling of the overpouch.
Drug Research > Drug Delivery > News
See more Drug Delivery news

Latest Drug Delivery News and Insight

View all Drug Delivery news or find news targeted to your interests
Alpex Services
Alpex Pharma is a drug delivery business focused on the development and commercial manufacature of effervescent and propriety rapidly dissolving (fast melt) pharmaceutical and nutraceutical products.
Drug Research > Drug Delivery > Products
Novavax' RSV F-protein nanoparticle vaccine gets FDA fast track status
By PBR Staff Writer
Biopharmaceutical firm Novavax has received fast track designation from the US Food and Drug Administration (FDA) for its RSV F-Protein nanoparticle vaccine candidate (RSV F vaccine) for protection of infants via maternal immunization.
Drug Research > Drug Delivery > News
Navidea's sentinel lymph node detection agent Lymphoseek gets marketing approval in Europe
By PBR Staff Writer
Navidea Biopharmaceuticals has received marketing authorization from the European Commission for Lymphoseek (technetium Tc 99m tilmanocept) injection 250mg kit.
Drug Research > Drug Delivery > News
Pfizer launches meningococcal group B vaccine Trumenba in US
By PBR Staff Writer
Pfizer has launched Trumenba (Meningococcal Group B Vaccine) in the US for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B in people aged between ten and 25 years.
Drug Research > Drug Delivery > News
Bayer gets approval in Japan for Eylea to treat diabetic macular edema
By PBR Staff Writer
Bayer HealthCare's Japanese subsidiary has received approval from the Ministry of Health, Labour and Welfare (MHLW) in Japan for Eylea (aflibercept solution for injection) to treat patients with diabetic macular edema (DME).
Drug Research > Drug Delivery > News
Novavax starts patient enrolment in Phase II trial of quadrivalent seasonal influenza VLP
By PBR Staff Writer
Novavax has started enrolling patients in a Phase II clinical trial of its recombinant quadrivalent seasonal influenza virus-like particle (VLP) vaccine candidate (Seasonal Influenza VLP).
Drug Research > Drug Delivery > News
Pfizer to expand Sayana Press contraceptive access to poor countries
Pfizer, the Bill & Melinda Gates Foundation and the Children’s Investment Fund Foundation (CIFF) announced an agreement that will expand access to Pfizer’s injectable contraceptive, Sayana Press (medroxyprogesterone acetate), for women most in need in 69 of the world’s poorest countriesi.
Drug Research > Drug Delivery > News
AstraZeneca, Isis to jointly develop targeted oligonucleotide delivery methods
By PBR Staff Writer
AstraZeneca and Isis Pharmaceuticals have entered into a strategic alliance to discover and develop new delivery methods for antisense oligonucleotides.
Drug Research > Drug Delivery > News
VaxInnate completes patient enrollment in VAX2012Q Phase I influenza vaccine trial
By PBR Staff Writer
US-based biotechnology firm VaxInnate completed patient enrollment in the Phase I trial of its experimental recombinant quadrivalent seasonal influenza vaccine, VAX2012Q.
Drug Research > Drug Delivery > News
NNIT in the Press
NNIT has more than 2,300 employees - more than 700 employees work outside the borders of Denmark – in China​​, the Czech Republic​, the ​Philippines​, Switzerland​ and in the US.
Drug Research > Drug Delivery > Press Releases
View all Drug Delivery news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250